![](https://hbhi.jhu.edu/sites/default/files/styles/highlights/public/2022-12/Publications_1.png?h=a31ffb6c)
November 2, 2022 | Publication
Estimating Savings Opportunities From Therapeutic Substitutions of High-Cost Generic Medications
In this cross-sectional analysis of the top 1000 generics in Colorado’s all-payer claims database in 2019, 45 high-cost generics that had lower-cost therapeutic alternatives of same clinical value were identified. Overall, high-cost generics were 15.6 times more expensive than their therapeutic alternatives (median values); if the lower-cost alternatives had been used, total spending would have been reduced by 88.3%.